Andere Kunden interessierten sich auch für
![Controlled release anti-inflammatory microsponge for colon targeting]( "Controlled release anti-inflammatory microsponge for colon targeting")
Controlled release anti-inflammatory microsponge for colon targeting36,99 €![Eudragit RS 100 microspheres of a topical antifungal drug]( "Eudragit RS 100 microspheres of a topical antifungal drug")
Eudragit RS 100 microspheres of a topical antifungal drug27,99 €![Miconazole Nitrate Microsponge For Topical Drug Delivery System]( "Miconazole Nitrate Microsponge For Topical Drug Delivery System")
Miconazole Nitrate Microsponge For Topical Drug Delivery System41,99 €![Design and Evaluation of Mometasone Furoate loaded Microsponge Gel]( "Design and Evaluation of Mometasone Furoate loaded Microsponge Gel")
Design and Evaluation of Mometasone Furoate loaded Microsponge Gel36,99 €![Nutriose-Eudragit Coated Pellets For Colon Targeted Drug Delivery]( "Nutriose-Eudragit Coated Pellets For Colon Targeted Drug Delivery")
Nutriose-Eudragit Coated Pellets For Colon Targeted Drug Delivery33,99 €![Topical Microemulgel Delivery for Budesonide]( "Topical Microemulgel Delivery for Budesonide")
Topical Microemulgel Delivery for Budesonide36,99 €![Polyherbal Anti-Inflammatory Topical Gel]( "Polyherbal Anti-Inflammatory Topical Gel")
Polyherbal Anti-Inflammatory Topical Gel32,99 €
The aim of the present study was to prepare microsponges gel formulation containing lornixicam by quasi emulsion solvent diffusion method. Lornoxicam is a Non-steroidal anti-inflammatory drug used for the treatment of various inflammatory diseases. Microsponges were spherical, uniform in shape, between 19 to 136mim in diameter. The production yield, actual drug content and encapsulation efficiency was found in the range of 57.14±0.47 to 88.57±0.799%, 54.78±0.76 to 83.55±0.65%, and 65.73±0.35 % to 95.04±0.42 respectively. The results of compatibility studies FTIR, PXRD, DSC and accelerated stability studies showed that no chemical interaction with drug and excipients. The dermal observation of skin irritation study shows no sign of either erythema or edema after 24 hrs of application. In % inhibition was more in microsponges gel as compare with pure drug gel in anti- inflammatory activity. Formulation of lornoxicam microsponges provides better control over release of drug. This study presents a new approach based on microsponge drug delivery system for topical application.